Remove tag point-care
article thumbnail

PharmaShots Weekly Snapshots (May 15 - 19, 2023)

PharmaShots

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

article thumbnail

Paw-sitively Efficient Inventory Management for Veterinary Professionals

epicur

Nicole is also the founder of Veterinary Care Logistics and Veterinary Inventory Strategy Network. From Nicole: Veterinary professionals, your mission is clear: Provide top-notch care for our four-legged friends. These tools are tailored to your needs, helping you track stock levels, reorder points, and expiration dates with ease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER). The standard of care for the condition includes blood transfusions, hydroxyurea and iron chelation.

59
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Joanna Carlish. Content consistency. Personalising marketing content.

article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

52
article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

Chronic care services managed by a doctor of pharmacy, PharmD, is a critical addition to a medical practice, but they are not widely engaged with these responsibilities. Chronic care services managed by a PharmD provides increased interaction with patients between regular visits with the primary care provider.

article thumbnail

Gilead tags Merck for first-line triple negative breast cancer trial

pharmaphorum

Hopefully a new standard of care for the aggressive disease, according to partners Gilead Sciences and Merck & Co. Analysts welcomed the performance but also noted it points to underlying weakness at the company. The post Gilead tags Merck for first-line triple negative breast cancer trial appeared first on.